Skip to main content
NCBI home page
Public Health Reports logoLink to Public Health Reports
. 1984 Jul-Aug;99(4):342–350.

Toxic shock syndrome: chronology of state and federal epidemiologic studies and regulatory decision-making.

M E Donawa, G R Schmid, M T Osterholm
PMCID: PMC1424608  PMID: 6431480

Full text

PDF
342

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cohen M. L., Graves L. M., Hayes P. S., Gibson R. J., Rasheed J. K., Feeley J. C. Toxic shock syndrome: modification and comparison of methods for detecting marker proteins in Staphylococcus aureus. J Clin Microbiol. 1983 Aug;18(2):372–375. doi: 10.1128/jcm.18.2.372-375.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Davis J. P., Chesney P. J., Wand P. J., LaVenture M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med. 1980 Dec 18;303(25):1429–1435. doi: 10.1056/NEJM198012183032501. [DOI] [PubMed] [Google Scholar]
  3. Davis J. P., Vergeront J. M. The effect of publicity on the reporting of toxic-shock syndrome in Wisconsin. J Infect Dis. 1982 Apr;145(4):449–457. doi: 10.1093/infdis/145.4.449. [DOI] [PubMed] [Google Scholar]
  4. Osterholm M. T., Davis J. P., Gibson R. W., Mandel J. S., Wintermeyer L. A., Helms C. M., Forfang J. C., Rondeau J., Vergeront J. M. Tri-state toxic-state syndrome study. I. Epidemiologic findings. J Infect Dis. 1982 Apr;145(4):431–440. doi: 10.1093/infdis/145.4.431. [DOI] [PubMed] [Google Scholar]
  5. Osterholm M. T., Forfang J. C. Toxic-shock syndrome in Minnesota: results of an active-passive surveillance system. J Infect Dis. 1982 Apr;145(4):458–464. doi: 10.1093/infdis/145.4.458. [DOI] [PubMed] [Google Scholar]
  6. Reingold A. L., Hargrett N. T., Dan B. B., Shands K. N., Strickland B. Y., Broome C. V. Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann Intern Med. 1982 Jun;96(6 Pt 2):871–874. doi: 10.7326/0003-4819-96-6-871. [DOI] [PubMed] [Google Scholar]
  7. Reingold A. L., Hargrett N. T., Shands K. N., Dan B. B., Schmid G. P., Strickland B. Y., Broome C. V. Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med. 1982 Jun;96(6 Pt 2):875–880. doi: 10.7326/0003-4819-96-6-875. [DOI] [PubMed] [Google Scholar]
  8. Schlech W. F., 3rd, Shands K. N., Reingold A. L., Dan B. B., Schmid G. P., Hargrett N. T., Hightower A., Herwaldt L. A., Neill M. A., Band J. D. Risk factors for development of toxic shock syndrome. Association with a tampon brand. JAMA. 1982 Aug 20;248(7):835–839. [PubMed] [Google Scholar]
  9. Schlievert P. M., Shands K. N., Dan B. B., Schmid G. P., Nishimura R. D. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis. 1981 Apr;143(4):509–516. doi: 10.1093/infdis/143.4.509. [DOI] [PubMed] [Google Scholar]
  10. Shands K. N., Schmid G. P., Dan B. B., Blum D., Guidotti R. J., Hargrett N. T., Anderson R. L., Hill D. L., Broome C. V., Band J. D. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med. 1980 Dec 18;303(25):1436–1442. doi: 10.1056/NEJM198012183032502. [DOI] [PubMed] [Google Scholar]

Articles from Public Health Reports are provided here courtesy of SAGE Publications

RESOURCES